Artificial Organ And Bionics Market - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Artificial Organ And Bionics Market

Description:

The global artificial organ and bionics market is expected to reach USD 38.75 billion by 2020 – PowerPoint PPT presentation

Number of Views:8

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Artificial Organ And Bionics Market


1
Artificial Organ Bionics Market Size, Share
Trends Analysis Report and Segment Forecast,
2020 Grand View Research, Inc
The global artificial organ and bionics market
is expected to reach USD 38.75 billion by 2020
at an estimated CAGR of 9.3 from 2014 to 2020.
  • The global Artificial Organ And Bionics Market is
    expected to reach USD 38.75 billion by 2020 at an
    estimated CAGR of 9.3 from 2014 to 2020,
    according to a new study by Grand View Research,
    Inc. Increasing prevalence of acute renal
    failure and renal disorders due to lifestyle
    habits such as excessive alcohol consumption and
    growing geriatric population base causing a rise
    in organ failure rates is expected to serve this
    market as a high impact rendering driver. In
    addition, growing incidence rates of accidents is
    expected to boost the demand for organ
    transplants, thus increasing demand for
    artificial organ. Artificial kidney dominated the
    global market in 2013, with revenue estimated at
    over USD 12.21 billion demand is expected grow
    due to the increasing chronic kidney patients.
    Artificial liver is the fastest growing market
  • To request a sample copy or view summary of this
    report, click the link below
  • http//www.grandviewresearch.com/industry-analysis
    /artificial-organ-and-bionics
  • Further key findings from the study suggest
  • Brain bionics in the medical bionics market held
    the largest share of revenue for the year 2013
    and the market is expected to grow at an
    estimated CAGR of 40.0.The presence of high
    unmet medical needs in neurology disease segment
    coupled with expensive treatment procedures is
    expected to drive the market for brain bionics.
    Exoskeleton is the fastest growing segment and is
    expected to grow at a CAGR of 16.0 from 2014 to
    2020.
  • North America was the largest regional market in
    2013, accounting for over 42.0 of global revenue
    due to the increasing population and awareness
    among the patients and the players.

2
  • Asia Pacific is the fastest growing market and is
    expected to grow at a CAGR of 11.0 from 2014 to
    2020 on account of rising demand due to the
    improvement in healthcare facilities, medical
    tourism and others.Increasing income levels and
    healthcare expenditure is expected to interest of
    the players in the emerging markets.
  • Key industry participants include Abiomed Inc.,
    Asahi Kasei Kuraray Medical Co. Ltd., Thoratec
    Corporation, WorldHeart Corp., Gambro AB and
    others.
  • Grand View Research has segmented the global
    artificial organ and bionics market on the basis
    of product, technology and region
  • Artificial Organ Product Outlook
  • Artificial organs
  • Total artificial heart
  • Artificial liver
  • Artificial pancreas
  • Artificial lungs
  • Artificial kidney

3
  • Brain bionics
  • Deep brain stimulators
  • Spinal cord stimulators
  • Vagus nerves stimulators
  • Vision bionics
  • Artificial Organ Technology Outlook
  • Mechanical bionics
  • Electronic bionics
  • Artificial Organ Regional Outlook
  • North America

4
  • Table of Content of Artificial Organ And Bionics
    Market
  • Chapter 1. Executive Summary
  • 1.1. Artificial organ - Industry Summary
    Critical Success Factors (CSFs)
  • Chapter 2. Artificial organ Industry Outlook
  • Market Segmentation
  • Market Size and Growth Prospects
  • Artificial organ Market Dynamics
  • Market Driver Analysis
  • Market Restraint Analysis
  • Key Opportunities Prioritized
  • Industry Analysis - Porter's
  • Artificial organ - Company Market Share Analysis,
    2013
  • Artificial organ market PESTEL Analysis, 2013
  • Chapter 3. Artificial organ Product Outlook
  • Artificial organs
  • Global artificial organ demand, 2012 - 2020 (USD
    Million)
  • Global total artificial heart demand, 2012 - 2020
    (USD Million)
  • Global artificial pancreas demand, 2012 - 2020
    (USD Million)

5
  • Global Spinal cord stimulators demand, 2012 -
    2020 (USD Million)
  • Global Deep brain stimulators demand, 2012 - 2020
    (USD Million)
  • Global Vagus nerve stimulators demand, 2012 -
    2020 (USD Million)
  • Global Exoskeletons demand, 2012 - 2020 (USD
    Million)
  • Global Bionic limbs demand, 2012 - 2020 (USD
    Million)
  • Global Bionic hands demand, 2012 - 2020 (USD
    Million)
  • Global Bionic legs demand, 2012 - 2020 (USD
    Million)
  • Global Vision bionics demand, 2012 - 2020 (USD
    Million)
  • Chapter 4. Artificial Organ Technology Outlook
  • Mechanical bionics
  • Global mechanical bionic demand, 2012 - 2020 (USD
    Million)
  • Electronic bionics
  • Global electronic demand, 2012 - 2020 (USD
    Million) Chapter 5. Artificial organ Regional
    Outlook
  • North America
  • North America artificial organmarket revenue by
    product, 2012 - 2020 (USD Million)
  • North America artificial organmarket revenue by
    technology, 2012 - 2020 (USD Million)
  • Europe
  • Europe artificial organmarket revenue by product,
    2012 - 2020 (USD Million)
  • Europe artificial organmarket revenue by
    technology, 2012 - 2020 (USD Million)

6
  • 6.1.4 Strategic Initiatives
  • Asahi Kasei Kuraray Medical Co. Ltd.
  • Company Overview
  • Financial Performance
  • Product Benchmarking
  • Strategic Initiatives
  • Thoratec Corporation
  • Company Overview
  • Financial Performance
  • Product Benchmarking
  • Strategic Initiatives
  • WorldHeart Corp.
  • Company Overview
  • Financial Performance
  • Product Benchmarking
  • Strategic Initiatives
  • Gambro AB
  • Company Overview
  • Financial Performance

7
  • Berlin Heart Gmbh
  • Company Overview
  • Financial Performance
  • Product Benchmarking
  • Strategic Initiatives
  • Ekso Bionics
  • Company Overview
  • Financial Performance
  • Product Benchmarking
  • Strategic Initiatives
  • Medtronic Inc.
  • Company Overview
  • Financial Performance
  • Product Benchmarking
  • Strategic Initiatives
  • Lifenet Health
  • Company Overview
  • Financial Performance
  • Product Benchmarking

8
  • Company Overview
  • Financial Performance
  • Product Benchmarking
  • Strategic Initiatives
  • Boston Scientific Corporation
  • Company Overview
  • Financial Performance
  • Product Benchmarking
  • Strategic Initiatives
  • Sorin S.P.A.
  • Company Overview
  • Financial Performance
  • Product Benchmarking
  • Strategic Initiatives
  • Chapter 7 Methodology and Scope
  • Research Methodology
  • Research Scope Assumptions
  • List of Data Sources

9
Toll Free 1-888- 202-9519 Email
sales_at_grandviewresearch.com For More Information
https//www.grandviewresearch.com Blog
https//healthcareforecastreport.blogspot.com/
About PowerShow.com